Medicinal Chemistry Research Group
Research Centre for Natural Sciences, Budapest

Our research group has been established in 2013 by György M. Keserű on the basis of a preceding synthetic organic chemistry group. Since then we established national and international, government and industry founded research programs focusing on two major topics:

  • fragment based approaches in the lead discovery of GPCR and kinase targets
  • chemical process development for small molecule active pharmaceutical ingredients

Funding agencies


Research portfolio D-amino acid oxidase (DAAO) inhibitors for the treatment of cognitive impairment associated with schizophrenia (CIAS) Allosteric GPCR ligands for psychiatric indications (mild cognitive impairment (MCI), anxiety disorders, authism spectrum disease (ASD)) Janus kinase 2 (JAK2) inhibitors for the treatment of myleopoliferative diseases OncoKids: discovery of cancer biomarkers for pediatric malignancies